Please assess the completion status of the following clinical trial:

Trial Title: Management of Women With an Incomplete Miscarriage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Women with confirmed incomplete induced miscarriage, less than 12 weeks' gestation.~2. No known allergy to misoprostol.~3. Women who will be haemodynamically stable.~4. Good access to emergency facilities. Exclusion~1. Women with signs of severe infection ( fever \> 38°) 2. Women with severe vaginal bleeding 3. Women known to have allergy to prostaglandins 4. Severe abdominal pain requiring immediate intervention

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Misoprostol group (Type: OTHER): The women received misoprostol 800 µg (Misotac 200 µg tablets, SIGMA pharmaceutical, Egypt) once dose placed in the posterior vaginal fornix
- Expectant group (Type: NO_INTERVENTION): Women did not receive any medication.

Based on this trial design, predict the completion outcome and termination type (if applicable).